Industrial Property Act 2019Section 23
23. Compulsory licence for patent
(1) Subject to subsection (3), where the competent authority is
satisfied that –
(a) the public interest, including national security, nutrition,
health or the development of other vital sectors of the
national economy, so requires;
(b) a judicial or administrative body has determined that the
manner of exploitation, by the owner of a patent or his
licensee, is anti-competitive, and that the exploitation
of the invention in accordance with this subsection
would remedy such practice;
(c) the owner of the patent is abusively exercising his
exclusive rights or neglecting to take measures to prevent
his licensee from abusively exercising those rights; or
(d) the invention is not available in sufficient quantities
or quality or at predetermined reasonable prices in
Mauritius,
he may, without the consent of the owner of the patent, authorise a
Government agency or a third party to exploit the patented invention.
(2) (a) Subject to subsection (3), where the competent
authority is satisfied that, without infringing a first patent, an application
for a second patent relates to an invention which involves an important
technical advancement of considerable economic significance in relation
to an invention claimed in the first patent, it may, on an application from
the new inventor and without the consent of the owner of the first patent,
issue a compulsory licence to the inventor of the second patent on payment
of the prescribed fee.
(b) An application for the issue of a compulsory licence
shall be accompanied by the payment of such non-refundable fee as may
be prescribed.
Acts 2019 503
(3) An application for a compulsory licence under subsection
(2) shall be accompanied by evidence that the owner of the patent has
received, from the person seeking the compulsory licence, a request for an
authorisation to exploit the second patent, but that person has been unable
to obtain such a licence on reasonable commercial terms and conditions
and within a reasonable time which shall, unless the competent authority in
exceptional circumstances otherwise determines, be 6 months from the date
on which the request for authorisation to exploit the second patent was made.
(4) No evidence of a request for an authorisation referred
to in subsection (3) shall be required in cases of national emergency,
circumstances of extreme urgency, cases of public non-commercial use
or where the compulsory licence is to be granted to remedy a practice
determined, after judicial or administrative process, to be anti-competitive,
where the owner of the patent is, as soon as reasonably practicable, notified
of the decision of the competent authority.
(5) No request for a compulsory licence on the ground of
insufficient availability as specified in subsection (1)(d) shall be made
before the expiry of a period of –
(a) 4 years from the filing date of the application for the
patent; or
(b) 3 years from the date of the grant of the patent,
whichever period expires last.
(6) A request under subsection (5) shall be refused where the
owner of the patent justifies his inaction or insufficient action by legitimate
reasons.
(7) The owner of a patent or any interested party may make a
request to be heard by the competent authority before it makes a decision
under subsection (1).
(8) (a) The exploitation of the invention shall be –
(i) limited to the purpose for which it was
licensed; and
504 Acts 2019
(ii) subject to the payment of an adequate
remuneration, to be determined by the competent
authority depending on the circumstances of
each case, to the owner of the patent.
(b) The competent authority shall, in determining the
remuneration under paragraph (a)(ii), take into account –
(i) the economic value of his decision; and
(ii) the need to correct anti-competitive practices.
(c) The competent authority shall, in determining the
remuneration with respect to the compulsory licence for a patent claiming
a pharmaceutical product or a process of making a pharmaceutical product,
prescribe an alternative process of making the same product which is not
known or is unavailable, by taking into account, where applicable, the
terms and conditions of the decision of 30 August 2003.
(9) The owner of a patent or holder of a compulsory licence
may request the competent authority to vary the terms of the decision
authorising the exploitation of the patented invention on the ground of
changed circumstances after hearing the parties.
(10) The owner of a patent may make a written request to the
competent authority to terminate a compulsory licence.
(11) Where, after hearing the parties, the competent authority is
satisfied that –
(a) the circumstances which led to its decision under
subsection (1) have ceased to exist and are unlikely to
recur;
(b) the holder of a compulsory licence has failed to comply
with the terms of its decision; or
(c) the need for adequate protection of the legitimate
interests of the holder of the licence does not justify the
maintenance of its decision,
he shall terminate the compulsory licence.
Acts 2019 505
(12) A compulsory licence may only be transferred to –
(a) the enterprise or business of the holder of the licence; or
(b) the part of the enterprise or business where the patented
invention is being exploited.
(13) A compulsory licence shall be non-exclusive and shall not
exclude –
(a) the exploitation of the invention by the patent owner
himself, through manufacture in Mauritius or through
importation, or both;
(b) the conclusion of licence contracts by the owner of the
patent; and
(c) the continued exercise, by the owner of the patent, of his
rights under section 21(1).
(14) The exploitation of an invention by the holder of a
compulsory licence shall predominantly be for the supply of the market in
Mauritius except where –
(a) it is permitted to remedy a practice which is
anti-competitive according to subsection (1)(b);
(b) the compulsory licence concerns a patent claiming
a pharmaceutical product or a process of making a
pharmaceutical product, and the purpose of the licence
is to export the patented products;
(c) the products manufactured by the patented process
are for a foreign territory or country with no, or with
insufficient, manufacturing capacity, in accordance
with the terms and conditions of the decision of
30 August 2003.
(15) Where a compulsory licence is granted –
(a) the owner of the first patent shall be entitled to a
cross-licence, on reasonable terms, to use the invention
claimed in the second patent; and
506 Acts 2019
(b) the use authorised in respect of the first patent shall
be non-assignable except with the assignment of the
second patent.
(16) This section shall apply, where appropriate and with such
modifications as may be necessary, to a pending application for a patent
except in the case of insufficient availability of the patented product or of
the product manufactured with the patented process.